Table 3.
Unvaccinated |
Once vaccinated |
Double vaccinated |
Total |
||||||
---|---|---|---|---|---|---|---|---|---|
Medication (n, %) | 172 | % | 31 | % | 1308 | % | 1511 | % | p-value |
SABA | 147 | 85.47 | 26 | 83.87 | 1022 | 78.13 | 1173 | 77.63 | 0.030 |
LAMA | 14 | 8.14 | 1 | 3.23 | 146 | 11.16 | 161 | 10.66 | 0.086 |
LABA | 3 | 1.74 | 1 | 3.23 | 56 | 4.28 | 60 | 3.97 | 0.130 |
LABA and LAMA | 46 | 26.74 | 9 | 29.03 | 411 | 31.42 | 466 | 30.84 | 0.236 |
ICS and LABA | 27 | 15.70 | 7 | 22.58 | 131 | 10.02 | 165 | 10.92 | 0.003 |
LABA and LAMA and ICS | 79 | 45.93 | 13 | 41.94 | 525 | 40.14 | 617 | 40.83 | 0.172 |
Rare combination | 3 | 1.74 | 0 | 0.00 | 27 | 2.06 | 30 | 1.99 | 0.409 |
No data available | 0 | 0.00 | 0 | 0.00 | 12 | 0.92 | 12 | 0.79 | 0.202 |
Data are presented as frequency and percentage; SABA: short-acting bronchodilators; LABA: long-acting bronchodilators; LAMA: long-acting muscarinic antagonist; ICS: inhaled corticosteroids; p < 0.05 means the two indicators were significantly correlated;